Skip to main content

Parenting

What's new

A remote six-month clinical trial is recruiting 150 children between the ages of two to five whose families are interested in trying automated insulin delivery. The study will evaluate the use of automated insulin delivery in young children to see if it improves Time in Range and other health metrics. Continue Reading »

The latest innovations in diabetes technology have brought Time in Range (TIR) to the forefront of diabetes care. Read to learn about the most exciting TIR news from one of the biggest international diabetes conferences of the year, with a special focus on automated insulin delivery systems for kids, adults, and seniors. Continue Reading »

Provention Bio’s new injectable drug was recommended by an FDA committee for approval on May 25, 2021. Studies show that Teplizumab can delay, for people at risk for type 1, the onset of the condition for two years or more. Learn what happened at the FDA meeting and what might come next. Continue Reading »

The diaTribe team covers the latest in diabetes technology from the 14th annual ATTD 2021 international conference (set virtually this year). Here are our top highlights from day one – stay tuned for updates on the rest of the conference! Continue Reading »

Time in Range (TIR) is another number for people with diabetes to pay attention to and use to improve their daily diabetes management. We talked with three women in the diabetes community about how they use TIR as a helpful number to keep them on track and inform their care. Continue Reading »

How can fruit affect blood sugar, and are there certain types of fruit that are better for people with diabetes? Continue Reading »

Zegalogue emergency glucagon comes as a pre-filled injection or auto-injector pen and can be used to treat severe hypoglycemia quickly.  Continue Reading »

When can people with diabetes feel normal again following the COVID-19 crisis? When can we stop wearing masks, start seeing friends and family, and comfortably send kids to school? Continue Reading »

Pages